Eva Klein
Impact in
- Immunology top 0.1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Oncology top 0.5%
- Viral-associated cancers and disorders
- CAR-T cell therapy research
Papers in
- Immunology 194
- Immune Cell Function and Interaction 122
- T-cell and B-cell Immunology 54
- Immunotherapy and Immune Responses 52
- Oncology 125
- Viral-associated cancers and disorders 73
- Co-authors
- George Klein (74 shared papers)Hans Wigzell (3 shared papers)Rolf Kiessling (5 shared papers)George Klein (31 shared papers)Hans Olof Sjögren (5 shared papers)Hugh F. Pross (1 shared paper)Mitsuo Takasugi (2 shared papers)Farkas Vánky (18 shared papers)
- Journals
- International Journal of Cancer (50 papers)Cellular Immunology (29 papers)Immunology Letters (22 papers)European Journal of Immunology (21 papers)JNCI Journal of the National Cancer Institute (17 papers)
- Partner nations
- SwedenUnited StatesHungary
In The Last Decade
Eva Klein
304 papers receiving 11.8k citations
Eva Klein's Hit Papers
Peers
Comparison fields: 5 of 154
- Immunology 7.6k
- Oncology 4.6k
- Pathology and Forensic Medicine 1.6k
- Hematology 827
- Genetics 748
Countries citing papers authored by Eva Klein
This map shows the geographic impact of Eva Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Klein more than expected).
Fields of papers citing papers by Eva Klein
This network shows the impact of papers produced by Eva Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Klein. The network helps show where Eva Klein may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 310 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | „Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype Hit paper breakdown → | 1975 | 1403 |
| 2 | „Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell Hit paper breakdown → | 1975 | 852 |
| 3 | Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Hit paper breakdown → | 1968 | 772 |
| 4 | Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Hit paper breakdown → | 1960 | 565 |
| 5 | Evolution of tumours and the impact of molecular oncology Hit paper breakdown → | 1985 | 539 |
| 6 | A MICROASSAY FOR CELL-MEDIATED IMMUNITY Hit paper breakdown → | 1970 | 389 |
| 7 | 1976 | 341 | |
| 8 | 1964 | 256 | |
| 9 | 1977 | 245 | |
| 10 | Conditioned tumorigenicity of activated oncogenes. | 1986 | 141 |
| 11 | 1973 | 128 | |
| 12 | 1969 | 118 | |
| 13 | 2010 | 118 | |
| 14 | 2014 | 109 | |
| 15 | 1973 | 106 | |
| 16 | Studies on cytotoxicity generated in human mixed lymphocyte cultures. II. Anti-K562 effectors are distinct from allospecific CTL and can be generated from NK-depleted T cells. | 1979 | 106 |
| 17 | 2013 | 102 | |
| 18 | 1966 | 98 | |
| 19 | 1984 | 94 | |
| 20 | 1985 | 93 |
About Eva Klein
Eva Klein is a scholar working on Immunology, Oncology, Molecular Biology, Epidemiology and Pathology and Forensic Medicine, having authored 310 papers that have together received 13.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (122 papers), Viral-associated cancers and disorders (73 papers), T-cell and B-cell Immunology (54 papers), Immunotherapy and Immune Responses (52 papers), Lymphoma Diagnosis and Treatment (43 papers), Monoclonal and Polyclonal Antibodies Research (39 papers), Cytomegalovirus and herpesvirus research (32 papers) and Virus-based gene therapy research (24 papers). The work is most often cited by research in Immunology (7.6k citations), Oncology (4.6k citations), Pathology and Forensic Medicine (1.6k citations), Hematology (827 citations) and Genetics (748 citations). Eva Klein has collaborated with scholars based in Sweden, United States and Hungary. Frequent co-authors include George Klein, Hans Wigzell, Rolf Kiessling, George Klein, Hans Olof Sjögren, Hugh F. Pross, Mitsuo Takasugi, Farkas Vánky, Peter Clifford and Noémi Nagy. Their work appears in journals such as International Journal of Cancer, Cellular Immunology, Immunology Letters, European Journal of Immunology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.